Skip to main content
Signal8

Full Access with Signal8 Pro, $49/mo billed annually.

Edesa Biotech, Inc. (EDSA) AI Dilution Summary

Updated Oct 8, 2026

Estimated cash was $31,670,992 as of 2026-08-21, rolled forward from $10,332,520 at 2026-06-30 against estimated monthly burn of $1,027,558. The most recent raise was a registered public offering closed 2026-08-21, which raised $23,100,000 net. Dilution here is driven primarily by the active H.C. Wainwright & Co., LLC ATM program, with $2,262,508 of remaining capacity and 1,571,625 shares sold since the program began through 2026-06-30, with sales after 2026-06-30 not yet reported.